An Introduction to Diabetic Retinopathy
Advances in pharmacotherapy following the introduction of anti-VEGF agents and intravitreal steroids have transformed the diabetic retinopathy treatment landscape; and new imaging techniques, such as optical coherence tomography-angiography (OCT-A), have helped to guide treatment.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Diabetic Retinopathy Content
APX3330 for the Treatment of Diabetic Retinopathy
touchREVIEWS in Ophthalmology. 2023;17(1):2–3 DOI: https://doi.org/10.17925/USOR.2023.17.1.2
Identifying treatments that prevent diabetic retinopathy progression is a priority in current research. Patients with non-proliferative retinopathy currently have limited treatment options to prevent the progression of retinopathy and loss of vision, and therapies such as anti–vascular endothelial growth factor (VEGF) therapy, steroid injectable therapy and laser treatment are reserved for patients who advance to proliferative diabetic retinopathy or diabetic macular oedema (DMO). The […]
Aflibercept in Diabetic Retinopathy
touchREVIEWS in Ophthalmology. 2021;15(1):18–22. DOI: https://doi.org/10.17925/OPHT.2021.15.1.23
The National Diabetes Statistics Report 2020 estimates that of the 34.1 million adults in the USA with diabetes in 2018, 21.4% had undiagnosed disease.1 Due to an insidious disease course, diabetic complications like diabetic retinopathy (DR) are common. Among US diabetic adults, 28.5% have DR and 4.4% have vision-threatening DR.2 DR remains the leading cause of new […]
Lloyd Clark, Kiaweh Eye 2021: Improvements in the Long-term Management of Diabetic Retinopathy and Diabetic Macular Oedema
It was a pleasure to speak with Lloyd Clark (Palmetto Retina Center, West Columbia, SC, USA) about injection protocols demonstrating improvements in the long-term management of diabetic retinopathy and diabetic macular oedema, and his views on current treatment trends. Questions What injection protocols have demonstrated improvements in the long-term management of diabetic retinopathy and diabetic […]
Lloyd Clark, Kiaweh Eye 2021: Diabetic Retinopathy and Diabetic Macular Oedema – Trends in Transitioning Treatment
Lloyd Clark (Palmetto Retina Center, West Columbia, SC, USA) shared with us his views on unresolved challenges in the treatment of diabetic retinopathy and diabetic macular oedema. Questions What are the unresolved challenges in the treatment of diabetic retinopathy and diabetic macular oedema? (00:22) How are dosing strategies evolving to maintain initial visual acuity gains, […]
Francesco Bandello, ESCRS 2020 – Anti-vascular Endothelial Growth Factor Agents and Laser for Treatment of Proliferative Diabetic Retinopathy
It was a pleasure to catch up with our Editorial Board member, Prof. Francesco Bandello (University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy), who talked us through his recent research on anti-vascular endothelial growth factor agents combined with laser for the treatment of proliferative diabetic retinopathy. Questions Could you tell us a little about your […]
Michael Abramoff, EURETINA 2019 – AI-based diabetic retinopathy screening
AI was a hot topic at ESRCS 2019, so we were honoured to meet with Michael Abramoff (University of Iowa) to discuss his latest research around an autonomous AI diagnostic system to assist with the diagnosis of diabetic retinopathy. Questions: 1. What are the limitations of current diagnosis of diabetic retinopathy? (0:04) 2. Could you […]
José Cunha Vaz, EURETINA 2019 – Advances in diabetic retinopathy
Jose Cunha-Vaz (AIBILI, Coimbra, Portugal) discusses the most important updates on diabetic retinopathy from EURETINA 2019, and shares advice with early career ophthalmologists on having a successful career. Questions: 1. What recent advances in diabetic retinopathy have had the biggest impact on your practice? 0:04 2. What are the most important updates in the area […]
Thomas Fenech, SOE 2019 – Updates in diabetic retinopathy
Thomas Fenech (Mater Dei Hospital, Msida, Malta) shares his thoughts on the most recent developments in diabetic retinopathy and the most promising areas of research for the future. Questions: 1. What have been the most significant recent developments in diabetic retinopathy? (0:04) 2. Discuss the current unmet needs and/or the challenges you face when treating […]
Matias Iglicki, SOE 2019 – ICO-Allergan Advanced Research Fellowship Award 2019
We caught up with Matias Iglicki, of the University of Buenos Aires, Argentina, at the SOE 2019 annual meeting. Dr Iglicki was recently awarded the ICO-Allergan Advanced Research Fellowship Award for his work in ‘Early Diagnosis of Diabetic Retinopathy Lesions using Telemedicine’, which he discusses in this video. 1. You were recently granted the ICO-Allergan […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!